Sounok Sengupta

4 ta ish

Department of Pharmacology, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India

1. Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer

   Sunil Kumar, Sounok Sengupta, Iqra Ali +4

   MaqolaQuinazolinone synthesis and applicationsJournal of Biomolecular Structure and Dynamics20231 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.000419

2. Discovery, lead identification and exploration of potential oxadiazole derivatives in targeting STAT3 as anti-cancer agents

   Vivek Panwar, Sounok Sengupta, Saroj Kumar +5

   MaqolaCytokine Signaling Pathways and InteractionsIn Silico Pharmacology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.000888

3. Recent advancements of nanoparticles for antiviral therapy

   Priyanku Pradip Das, Sounok Sengupta, Deepak Balram +5

   MaqolaRNA Interference and Gene DeliveryAdvances in Natural Sciences Nanoscience and Nanotechnology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.003065

4. Therapeutic potential of Bergenia ciliata against lung cancer: an integrative molecular docking, ADMET, and molecular dynamics approach

   Krittika Mukherjee, Sounok Sengupta, Ajay Kumar Singh +4

   MaqolaPhytochemistry and Bioactivity StudiesIn Silico Pharmacology20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.001194